(S)-1-(5-Fluoro-2-iodophenyl)ethan-1-ol, 97%, 5g

2,5-Dioxopyrrolidin-1-yl 4-(1,2,2-triphenylvinyl)benzoate, 97%, 100mg

3-Bromo-4-chloro-1H-pyrrolo[3,2-c]pyridine, 95.0%, 1g

(9-Oxo-9 H -acridin-10-yl)-acetic acid, 98.0%, 5g

5-Bromo-6-fluorobenzo[d][1,3]dioxole, 98%, 100mg

(3R,4R)-4-Aminotetrahydro-2H-pyran-3-ol, 95+%, 250mg

2-Chloro-5-pyrimidinecarbonitrile, 97.0%, 5g

(4-(3-(Trifluoromethyl)-3H-diazirin-3-yl)phenyl)methanamine hydrochloride, 97%, 100mg

2,4-Difluoronitrobenzene, 99.0%, 25g

Closing caps LABOCAP for 28/30 mm 100 pcs

4-(3-Bromophenyl)-6-Phenyldibenzo[b,d]Furan, 97%, 1g

N-Methyl-1-(4,5,6,7-tetrahydrobenzo[b]thiophen-3-yl)methanamine hydrochloride, 250mg

2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)acetic acid, 95.0%, 1g